WallStSmart

Forian Inc (FORA)vsHinge Health, Inc. (HNGE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Hinge Health, Inc. generates 2051% more annual revenue ($646.34M vs $30.05M). FORA leads profitability with a -17.0% profit margin vs -78.9%. HNGE earns a higher WallStSmart Score of 36/100 (F).

FORA

Avoid

29

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.0Quality: 5.0

HNGE

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 3.5Value: 5.0Quality: 5.0
Piotroski: 3/9Altman Z: -2.69

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FORA2 strengths · Avg: 8.0/10
PEG RatioValuation
0.948/10

Growing faster than its price suggests

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

HNGE2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
47.2%10/10

Revenue surging 47.2% year-over-year

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Areas to Watch

FORA4 concerns · Avg: 2.3/10
Market CapQuality
$67.79M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.9%2/10

ROE of -17.9% — below average capital efficiency

Revenue GrowthGrowth
-2.9%2/10

Revenue declined 2.9%

EPS GrowthGrowth
-89.1%2/10

Earnings declined 89.1%

HNGE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
43.4x2/10

Trading at 43.4x book value

Return on EquityProfitability
-197.2%2/10

ROE of -197.2% — below average capital efficiency

EPS GrowthGrowth
-68.4%2/10

Earnings declined 68.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : FORA

The strongest argument for FORA centers on PEG Ratio, Price/Book. PEG of 0.94 suggests the stock is reasonably priced for its growth.

Bull Case : HNGE

The strongest argument for HNGE centers on Revenue Growth, Debt/Equity. Revenue growth of 47.2% demonstrates continued momentum.

Bear Case : FORA

The primary concerns for FORA are Market Cap, Return on Equity, Revenue Growth.

Bear Case : HNGE

The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.

Key Dynamics to Monitor

FORA profiles as a turnaround stock while HNGE is a hypergrowth play — different risk/reward profiles.

HNGE is growing revenue faster at 47.2% — sustainability is the question.

HNGE generates stronger free cash flow (43M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HNGE scores higher overall (36/100 vs 29/100) and 47.2% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Forian Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Forian Inc. provides a suite of software solutions, data management capabilities, proprietary data, and predictive analytics to optimize and measure operational, clinical, and financial performance for clients in the health and cannabis industries, as well as dispensaries. , cannabis growers, manufacturers, and distributors. The company is headquartered in Newtown, Pennsylvania.

Hinge Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Visit Website →

Want to dig deeper into these stocks?